Differential properties of CBA/J mononuclear phagocytes recovered from an inflammatory site and probed with two different species of Leishmania

Microbes and Infection

Volumn 5, Issue 4, 2003, Pages 251-260

  Gomes, Ivana Nunes ^a   De Carvalho Calabrich, Aknar Freire ^a   Da Silva Tavares, Rafael ^a   Wietzerbin, Jeanne ^b   Rodrigues De Freitas, Luiz Antônio ^a   Tavares Veras, Patrícia Sampaio ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b INSTITUT CURIE   (France)

Author keywords

CBA J mice; L. amazonensis; Macrophages

Indexed keywords

GAMMA INTERFERON; NITRIC OXIDE; TUMOR NECROSIS FACTOR;

ANIMAL MODEL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; FEMALE; HOST PARASITE INTERACTION; IMMUNE RESPONSE; INFLAMMATION; LEISHMANIA MAJOR; LEISHMANIASIS; MALE; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REDUCTION;

LEISHMANIA AMAZONENSIS; LEISHMANIA MAJOR;

EID: 0037389770     PISSN: 12864579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1286-4579(03)00025-X     Document Type: Article

References (51)

1. Peters W., Killick-Kendrick R. The Leishmaniases. 1987;Academic Press Inc, London.
2. Grimaldi G., Tesh R.B. Leishmaniases of the New World: current concepts and implications for future research. Clin. Microbiol. Rev. 6:1993;230-250.
3. Locksley R.M., Heinzel F.P., Sadick M.D., Holaday B.J., Gardner Jr K.D. Murine cutaneous leishmaniasis: susceptibility correlates with differential expansion of helper T-cell subsets. Ann. Inst. Pasteur Immunol. 138:1987;744-749.
4. Heinzel F.P., Sadick M.D., Holaday B.J., Coffman R.L., Locksley R.M. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. J. Exp. M. 169:1989;59-72.
5. Heinzel F.P., Sadick M.D., Mutha S.S., Locksley R.M. Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. USA. 88:1991;7011-7015.
6. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
7. Lemos de Souza V., Ascencao Souza J., Correia Silva T.M., Sampaio Tavares Veras P., Rodrigues de Freitas L.A. Different Leishmania species determine distinct profiles of immune and histopathological responses in CBA mice. Microbes Infect. 2:2000;1807-1815.
8. Sadick M.D., Heinzel F.P., Holaday B.J., Pu R.T., Dawkins R.S., Locksley R.M. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J. Exp. M. 171:1990;115-127.
9. Chatelain R., Varkila K., Coffman R.L. IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148:1992;1182-1187.
10. Sypek J.P., Chung C.L., Mayor S.E., et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. M. 177:1993;1797-1802.
11. Diefenbach A., Schindler H., Donhauser N., et al. Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity. 8:1998;77-87.
12. Satoskar A.R., Stamm L.M., Zhang X., et al. Mice lacking NK cells develop an efficient Th1 response and control cutaneous Leishmania major infection. J. Immunol. 162:1999;6747-6754.
13. Laskay T., Diefenbach A., Rollinghoff M., Solbach W. Early parasite containment is decisive for resistance to Leishmania major infection. Eur. J. Immunol. 25:1995;2220-2227.
14. Prina E., Jouanne C., de Souza Leao S., Szabo A., Guillet J.G., Antoine J.C. Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes. J. Immunol. 151:1993;2050-2061.
15. Antoine J.C., Jouanne C., Lang T., Prina E., de Chastellier C., Frehel C. Localization of major histocompatibility complex class II molecules in phagolysosomes of murine macrophages infected with Leishmania amazonensis. Infect. Immun. 59:1991;764-775.
16. Mosser D.M., Karp C.L. Receptor mediated subversion of macrophage cytokine production by intracellular pathogens. Curr. Opin. Immunol. 11:1999;406-411.
17. Mauel J., Corradin S.B., Buchmuller Rouiller Y. Nitrogen and oxygen metabolites and the killing of Leishmania by activated murine macrophages. Res. Immunol. 142:1991;577-580. (discussion 593-594).
18. Liew F.Y., Li Y., Millott S. Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J. Immunol. 145:1990;4306-4310.
19. Murray H.W., Cartelli D.M. Killing of intracellular Leishmania donovani by human mononuclear phagocytes. Evidence for oxygen-dependent and -independent leishmanicidal activity. J. Clin. Invest. 72:1983;32-44.
20. Assreuy J., Cunha F.Q., Epperlein M., et al. Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major. Eur. J. Immunol. 24:1994;672-676.
21. Green S.J., Meltzer M.S., Hibbs J.B., Nacy C.A. Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism. J. Immunol. 144:1990;278-283.
22. Behin R., Mauel J., Sordat B. Leishmania tropica: pathogenicity and in vitro macrophage function in strains of inbred mice. Exp. Parasitol. 48:1979;81-91.
23. Handman E., Ceredig R., Mitchell G.F. Murine cutaneous leishmaniasis: disease patterns in intact and nude mice of various genotypes and examination of some differences between normal and infected macrophages. Aust. J. Exp. Biol. Med. Sci. 57:1979;9-29.
24. Nacy C.A., Fortier A.H., Meltzer M.S., Buchmeier N.A., Schreiber R.D. Macrophage activation to kill Leishmania major: activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-gamma and non-interferon lymphokines. J. Immunol. 135:1985;3505-3511.
25. Nacy C.A., Fortier A.H., Pappas M.G., Henry R.R. Susceptibility of inbred mice to Leishmania tropica infection: correlation of susceptibility with in vitro defective macrophage microbicidal activities. Cell. Immunol. 77:1983;298-307.
26. Scott P., Pearce E., Cheever A.W., Coffman R.L., Sher A. Role of cytokines and CD4+ T-cell subsets in the regulation of parasite immunity and disease. Immunol. Rev. 112:1989;161-182.
27. Ulrich M., Ortiz D.T., Convit J. The effect of fresh serum on the leptomonads of Leishmania I. Preliminary report. Trans. R. Soc. Trop. Med. Hyg. 62:1968;825-830.
28. Pick E. Microassays for superoxide and hydrogen peroxide production and nitroblue tetrazolium reduction using an enzyme immunoassaymicroplate reader. Methods Enzymol. 132:1986;407-421.
29. Nashleanas M., Scott P. Activated T cells induce macrophages to produce NO and control Leishmania major in the absence of tumor necrosis factor receptor p55. Infect. Immun. 68:2000;1428-1434.
30. Wilhelm P., Ritter U., Labbow S., et al. Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J. Immunol. 166:2001;4012-4019.
31. Theodos C.M., Povinelli L., Molina R., Sherry B., Titus R.G. Role of tumor necrosis factor in macrophage leishmanicidal activity in vitro and resistance to cutaneous leishmaniasis in vivo. Infect. Immun. 59:1991;2839-2842.
32. Wright S.D., Silverstein S.C. Receptors for C3b and C3bi promote phagocytosis but not the release of toxic oxygen from human phagocytes. J. Exp. M. 158:1983;2016-2023.
33. McNeely T.B., Rosen G., Londner M.V., Turco S.J. Inhibitory effects on protein kinase C activity by lipophosphoglycan fragments and glycosylphosphatidylinositol antigens of the protozoan parasite Leishmania. Biochem. J. 259:1989;601-604.
34. Da Silva R.P., Hall B.F., Joiner K.A., Sacks D.L. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J. Immunol. 143:1989;617-622.
35. Descoteaux A., Matlashewski G., Turco S.J. Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan. J. Immunol. 149:1992;3008-3015.
36. Courret N., Frehel C., Prina E., Lang T., Antoine J.C. Kinetics of the intracellular differentiation ofLeishmania amazonensisand internalization of host MHC molecules by the intermediate parasite stages. 122:2001;263-279.
37. Green S.J., Crawford R.M., Hockmeyer J.T., Meltzer M.S., Nacy C.A. Leishmania major amastigotes initiate the L-arginine-dependent killing mechanism in IFN-gamma-stimulated macrophages by induction of tumor necrosis factor-alpha. J. Immunol. 145:1990;4290-4297.
38. Cillari E., Dieli M., Maltese E., Milano S., Salerno A., Liew F.Y. Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-gamma. J. Immunol. 143:1989;2001-2005.
39. Juttner S., Bernhagen J., Metz C.N., Rollinghoff M., Bucala R., Gessner A. Migration inhibitory factor induces killing of Leishmania major by macrophages: dependence on reactive nitrogen intermediates and endogenous TNF-alpha. J. Immunol. 161:1998;2383-2390.
40. Martin E., Nathan C., Xie Q.W. Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J. Exp. M. 180:1994;977-984.
41. Kamijo R., Harada H., Matsuyama T., et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science. 263:1994;1612-1615.
42. Lonardoni M.V., Russo M., Jancar S. Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection. Infect. Immun. 68:2000;6355-6361.
43. Reiner N.E., Kazura J.W. Oxidant-mediated damage of Leishmania donovani promastigotes. Infect. Immun. 36:1982;1023-1027.
44. De Groote M.A., Fang F.C. NO inhibitions: antimicrobial properties of nitric oxide. Clin. Infect. Dis. 21:(Suppl 2):1995;S162-165.
45. Barral A., Teixeira M., Reis P., et al. Transforming growth factor-beta in human cutaneous leishmaniasis. Am. J. Pathol. 147:1995;947-954.
46. Barral_Netto M., Barral A., Brownell C.E., et al. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. Science. 257:1992;545-548.
47. Hoehn P., Goedert S., Germann T., et al. Opposing effects of TGF-beta 2 on the Th1 cell development of naive CD4+ T cells isolated from different mouse strains. J. Immunol. 155:1995;3788-3793.
48. Pawelec G., Rehbein A., Schlotz E., Friccius H., Pohla H. Cytokine modulation of TH1/TH2 phenotype differentiation in directly alloresponsive CD4+ human T cells. Transplantation. 62:1996;1095-1101.
49. Schmitt E., Hoehn P., Huels C., et al. T helper type 1 development of naive CD4+ T cells requires the coordinate action of interleukin-12 and interferon-gamma and is inhibited by transforming growth factor-beta. Eur. J. Immunol. 24:1994;793-798.
50. Swain S.L., Huston G., Tonkonogy S., Weinberg A. Transforming growth factor-beta and IL-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J. Immunol. 147:1991;2991-3000.
51. Powrie F., Menon S., Coffman R.L. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol. 23:1993;2223-2229.